Neoplasms, Prostate [clinicaltrials_resource:4e483f2c5472e67a0e2b73e538840933]
clinicaltrials:NCT00056407Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA [clinicaltrials:NCT00148928]clinicaltrials:NCT00363311clinicaltrials:NCT00470834clinicaltrials:NCT00558363ARI103094-Follow-Up Study for REDUCE Study Subjects [clinicaltrials:NCT00883909]clinicaltrials:NCT00970203Economic Analyses of the REDUCE Trial [clinicaltrials:NCT01337258]Korean Practice Patterns for Screening PCA(Prostate Cancer) [clinicaltrials:NCT01371513]Sipuleucel-T Manufacturing Demonstration Study [clinicaltrials:NCT01477749]clinicaltrials:NCT02153918Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer [clinicaltrials:NCT02349139]Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 [clinicaltrials:NCT02362464]
condition [clinicaltrials_vocabulary:condition]
Neoplasms, Prostate [clinicaltrials_resource:4e483f2c5472e67a0e2b73e538840933]
Bio2RDF identifier
4e483f2c5472e67a0e2b73e538840933
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4e483f2c5472e67a0e2b73e538840933
identifier
clinicaltrials_resource:4e483f2c5472e67a0e2b73e538840933
title
Neoplasms, Prostate
@en
label
Neoplasms, Prostate [clinicaltrials_resource:4e483f2c5472e67a0e2b73e538840933]
@en